It appears no script is enabled within your browser. Please enable JavaScript to use this site.
Skip header and navigation
Home
View Selections:
0
Items
Help
Print
The analysis by Manuel and colleagues creates controversy with headlines, not data.
https://arctichealth.org/en/permalink/ahliterature175310
Source
CMAJ. 2005 Apr 12;172(8):1033-4; discussion 1037
Publication Type
Article
Date
Apr-12-2005
More detail
Author
Jacques Genest
Ruth McPherson
Jiri Frohlich
George Fodor
Author Affiliation
Division of Cardiology, Royal Victoria Hospital, McGill University, Montréal, Que. jacques.genest@muhc.mcgill.ca
Source
CMAJ. 2005 Apr 12;172(8):1033-4; discussion 1037
Date
Apr-12-2005
Language
English
Publication Type
Article
Keywords
Canada
Cholesterol, LDL - blood
Coronary Disease - mortality - prevention & control
Health Expenditures
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
Hyperlipidemias - drug therapy
Hypolipidemic Agents - therapeutic use
Practice Guidelines as Topic
Risk factors
Notes
Cites: Circulation. 2003 Apr 22;107(15):2059-6512707251
Cites: JAMA. 1999 Dec 22-29;282(24):2340-610612322
Cites: JAMA. 2001 May 16;285(19):2486-9711368702
Cites: Circulation. 2001 Nov 27;104(22):2746-5311723030
Cites: Circulation. 2001 Dec 4;104(23):2855-6411733407
Cites: Lancet. 2002 Jul 6;360(9326):7-2212114036
Cites: CMAJ. 2005 Apr 12;172(8):1027-3115824409
Cites: CMAJ. 2003 Oct 28;169(9):921-414581310
Cites: Can J Public Health. 2004 Jan-Feb;95(1):16-2014768735
Cites: Circulation. 2004 Jul 13;110(2):227-3915249516
Cites: Lancet. 2004 Sep 11-17;364(9438):937-5215364185
Cites: BMJ. 1992 Jul 4;305(6844):15-91638188
Comment On: CMAJ. 2005 Apr 12;172(8):1027-3115824409
PubMed ID
15824410
View in PubMed
Less detail
Permalink